ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2019 American Transplant Congress

    Apolipoprotein L1 Genotyping in Potential African American Living Kidney Donors

    P. Gudsoorkar, M. Anand, T. Kaur, S. Shah, S. Bumb, A. Govil, B. G. Abu Jawdeh

    U.Cincinnati, Cincinnati, OH

    *Purpose: African Americans(AA) account for 13% of the US population, yet compose more than one third of dialysis patients. Inheriting two Apolipoprotein L1 gene (APOL1)…
  • 2019 American Transplant Congress

    Adjuvant Immunotherapeutic Approach For Liver Transplant Recipients With Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells

    M. Ohira1, R. Hotta1, Y. Imaoka1, K. Sato1, Y. Tanaka1, A. G. Tzakis2, S. Nishida3, H. Ohdan1

    1Hiroshima University, Hiroshima, Japan, 2Cleveland Clinic Florida, Weston, FL, 3New York Medical College, Valhalla, NY

    *Purpose: Although liver transplantation (LT) is a preferred treatment for selected patients with Hepatocellular carcinoma (HCC), HCC-recurrence would be a still important medical problem. Most…
  • 2019 American Transplant Congress

    Solving Target Recognition and Activation Mediated by Non-HLA Agonistic Antibodies Targeting ETAR

    A. Philippe1, R. Catar1, P. Scheerer2, M. Szczepek2, D. Dragun1

    1Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Berlin, Germany, 2Institute of Medical Physics and Biophysics, Charité Universitätsmedizin Berlin, Berlin, Germany

    *Purpose: Endothelin-1 type A receptor (ETAR) exhibits multiligand binding abilities and may signal upon natural ligand Endothelin-1 (ET-1) and non-HLA ETAR-agonistic IgG (ETAR-IgG)-mediated stimulation similar…
  • 2019 American Transplant Congress

    A Single-Center Experience with a 6-Month Regimen of Pneumocystis jiroveci Pneumonia Prophylaxis in HIV-Positive Kidney Transplant Recipients

    C. Mejia1, G. Malat2, D. H. Lee3, S. Epstein1, M. Harhay3, L. Levin Mizrahi3, K. Ranganna3

    1Drexel University, Philadelphia, PA, 2Hahnemann University Hospital, Philadelphia, PA, 3Medicine, Drexel University, Philadelphia, PA

    *Purpose: Pneumocystis jiroveci pneumonia (PJP) prophylaxis is recommended for all kidney transplant recipients (KTR) for after transplant. HIV-positive KTRs represent a unique subset, and there…
  • 2019 American Transplant Congress

    The Impact of Removing DSA as a First Unit of Lung Allocation: Preliminary Results

    R. R. Lehman1, K. Uccellini2, M. Skeans3, M. Valapour3, E. D. Lease4, R. Daly5, K. M. Chan6

    1Research, United Network for Organ Sharing, Richmond, VA, 2Policy, United Network for Organ Sharing, Richmond, VA, 3SRTR, Minneapolis, MN, 4Univ of Washington, Seattle, WA, 5Mayo Clinic, Rochester, MN, 6Univ of Michigan, Ann Arbor, MI

    *Purpose: In an emergency action on November 24, 2017 the Organ Procurement and Transplantation Network (OPTN) altered US lung allocation policy by replacing the donor…
  • 2019 American Transplant Congress

    Circulating Mirnas Regulate Gene Expression In Kidney Tissue During Transplant Glomerulopathy

    C. Kuscu1, V. Sai Bontha1, C. Kuscu1, D. Maluf1, A. Bajwa1, J. Eason1, V. Mas1, E. Akalin2

    1UTHSC, Memphis, TN, 2Albert Einstein College of Medicine, NYC, NY

    *Purpose: Post-transplant glomerular disease includes membranous glomerulopathy (MG), secondary or primary focal segmental glomerulosclerosis (FSGS). Furthermore, at post transplant, TG is an important cause of…
  • 2019 American Transplant Congress

    Predictors and Outcomes of Acute Graft-versus-Host Disease after Liver Transplant

    A. Caines1, S. Nagai2, R. Salgia1

    1Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI, 2Transplant Surgery, Henry Ford Health System, Detroit, MI

    *Purpose: Graft-versus-Host Disease (GVHD) is a rare complication of liver transplant (LT) that has an estimated incidence of 0.1%-2% per year and is associated with…
  • 2019 American Transplant Congress

    Evaluation of Medication Burden in Kidney Transplant Recipients at Time of Index Hospitalization

    J. Hardcopf1, H. Meadows1, T. Harrison1, H. Corbo1, B. O'brien1, J. N. Fleming1, C. Perez1, N. Patel1, N. Pilch1, P. K. Baliga2, D. DuBay2, D. Taber1

    1Department of Pharmacy Services, Medical University of South Carolina, Charleston, SC, 2Division of Transplant Surgery, Department of Surgery, Medical University of South Carolina, Charleston, SC

    *Purpose: This study will assess whether a higher number of medication changes from pre- to post-transplant lead to worse clinical outcomes and higher healthcare utilization…
  • 2019 American Transplant Congress

    Targeted Proteomic Analysis Detects Acute T Cell-Mediated Kidney Allograft Rejection in Belatacept-Treated Patients

    M. van der Zwan, D. A. Hesselink, M. C. Clahsen-van Groningen, C. C. Baan

    Erasmus MC, Rotterdam, Netherlands

    *Purpose: There is an unmet need for reliable minimally-invasive diagnostic biomarkers for immunological allograft monitoring and detection of acute kidney transplant rejection. Here, targeted proteomic…
  • 2019 American Transplant Congress

    Utilizing Ides To Eliminate Residual Antibodies Targeting Xenografts

    C. Rickert, K. Lee, N. Tanimine, J. Lei, A. Cuenca, N. Feeney, K. Deng, H. Yeh, J. F. Markmann

    Massachusetts General Hospital, Boston, MA

    *Purpose: A significant hinderance to the successful use of xenotransplantation has been the presence of preformed antibodies against the donor antigens, known as xenoantigens. Using…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 214
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences